173 related articles for article (PubMed ID: 19459852)
1. Acyl-CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide.
Mashima T; Sato S; Okabe S; Miyata S; Matsuura M; Sugimoto Y; Tsuruo T; Seimiya H
Cancer Sci; 2009 Aug; 100(8):1556-62. PubMed ID: 19459852
[TBL] [Abstract][Full Text] [Related]
2. p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target.
Mashima T; Oh-hara T; Sato S; Mochizuki M; Sugimoto Y; Yamazaki K; Hamada J; Tada M; Moriuchi T; Ishikawa Y; Kato Y; Tomoda H; Yamori T; Tsuruo T
J Natl Cancer Inst; 2005 May; 97(10):765-77. PubMed ID: 15900046
[TBL] [Abstract][Full Text] [Related]
3. Human intestinal acyl-CoA synthetase 5 is sensitive to the inhibitor triacsin C.
Kaemmerer E; Peuscher A; Reinartz A; Liedtke C; Weiskirchen R; Kopitz J; Gassler N
World J Gastroenterol; 2011 Nov; 17(44):4883-9. PubMed ID: 22171129
[TBL] [Abstract][Full Text] [Related]
4. Evidence for an essential role of long chain acyl-CoA synthetase in animal cell proliferation. Inhibition of long chain acyl-CoA synthetase by triacsins caused inhibition of Raji cell proliferation.
Tomoda H; Igarashi K; Cyong JC; Omura S
J Biol Chem; 1991 Mar; 266(7):4214-9. PubMed ID: 1999415
[TBL] [Abstract][Full Text] [Related]
5. Triacsin C: a differential inhibitor of arachidonoyl-CoA synthetase and nonspecific long chain acyl-CoA synthetase.
Hartman EJ; Omura S; Laposata M
Prostaglandins; 1989 Jun; 37(6):655-71. PubMed ID: 2505330
[TBL] [Abstract][Full Text] [Related]
6. Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions.
Mashima T; Sato S; Sugimoto Y; Tsuruo T; Seimiya H
Oncogene; 2009 Jan; 28(1):9-19. PubMed ID: 18806831
[TBL] [Abstract][Full Text] [Related]
7. Long chain acyl coenzyme A and signaling in neutrophils. An inhibitor of acyl coenzyme A synthetase, triacsin C, inhibits superoxide anion generation and degranulation by human neutrophils.
Korchak HM; Kane LH; Rossi MW; Corkey BE
J Biol Chem; 1994 Dec; 269(48):30281-7. PubMed ID: 7982939
[TBL] [Abstract][Full Text] [Related]
8. Wild-type p53-dependent etoposide-induced apoptosis mediated by caspase-3 activation in human glioma cells.
Yin D; Tamaki N; Kokunai T
J Neurosurg; 2000 Aug; 93(2):289-97. PubMed ID: 10930016
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of Cryptosporidium parvum infection in vitro and in vivo by targeting parasite fatty acyl-coenzyme A synthetases.
Guo F; Zhang H; Fritzler JM; Rider SD; Xiang L; McNair NN; Mead JR; Zhu G
J Infect Dis; 2014 Apr; 209(8):1279-87. PubMed ID: 24273180
[TBL] [Abstract][Full Text] [Related]
10. Eicosapentaenoic acid-induced apoptosis depends on acyl CoA-synthetase.
Heimli H; Hollung K; Drevon CA
Lipids; 2003 Mar; 38(3):263-8. PubMed ID: 12784866
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting long-chain fatty acyl CoA synthetase does not increase agonist-induced release of arachidonate metabolites from human endothelial cells.
Weis MT; Brady M; Moore M; Crumley J; Stallone JN
J Vasc Res; 2005; 42(4):275-83. PubMed ID: 15908751
[TBL] [Abstract][Full Text] [Related]
12. The acyl-CoA synthetase inhibitor triacsin C enhanced eicosanoid release in leukocytes.
Oh-ishi S; Yamaki K; Abe M; Tomoda H; Omura S
Jpn J Pharmacol; 1992 Jul; 59(3):417-8. PubMed ID: 1434135
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I decreased etoposide-induced apoptosis in glioma cells by increasing bcl-2 expression and decreasing CPP32 activity.
Yin D; Tamaki N; Parent AD; Zhang JH
Neurol Res; 2005 Jan; 27(1):27-35. PubMed ID: 15829155
[TBL] [Abstract][Full Text] [Related]
14. Expression and characterization of recombinant rat Acyl-CoA synthetases 1, 4, and 5. Selective inhibition by triacsin C and thiazolidinediones.
Kim JH; Lewin TM; Coleman RA
J Biol Chem; 2001 Jul; 276(27):24667-73. PubMed ID: 11319222
[TBL] [Abstract][Full Text] [Related]
15. Characterization of triacsin C inhibition of short-, medium-, and long-chain fatty acid: CoA ligases of human liver.
Vessey DA; Kelley M; Warren RS
J Biochem Mol Toxicol; 2004; 18(2):100-6. PubMed ID: 15122652
[TBL] [Abstract][Full Text] [Related]
16. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of acyl-CoA synthetase by triacsins.
Tomoda H; Igarashi K; Omura S
Biochim Biophys Acta; 1987 Oct; 921(3):595-8. PubMed ID: 3117118
[TBL] [Abstract][Full Text] [Related]
18. Acyl-CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently.
Lewin TM; Kim JH; Granger DA; Vance JE; Coleman RA
J Biol Chem; 2001 Jul; 276(27):24674-9. PubMed ID: 11319232
[TBL] [Abstract][Full Text] [Related]
19. Complete inhibition of mouse macrophage-derived foam cell formation by triacsin C.
Namatame I; Tomoda H; Arai H; Inoue K; Omura S
J Biochem; 1999 Feb; 125(2):319-27. PubMed ID: 9990129
[TBL] [Abstract][Full Text] [Related]
20. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.
Tamm I; Wang Y; Sausville E; Scudiero DA; Vigna N; Oltersdorf T; Reed JC
Cancer Res; 1998 Dec; 58(23):5315-20. PubMed ID: 9850056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
